Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

16 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Changing serological status and low vaccination-induced protection rates against hepatitis B characterize chronic hepatitis C virus-infected injecting drug users in Greece: need for immunization policy.
Elefsiniotis IS, Pantazis KD, Ketikoglou ID, Koutsounas SI, Tsianos EV. Elefsiniotis IS, et al. Among authors: koutsounas si. Eur J Gastroenterol Hepatol. 2006 Nov;18(11):1227-31. doi: 10.1097/01.meg.0000236888.51838.36. Eur J Gastroenterol Hepatol. 2006. PMID: 17033445
Pegylated interferon alfa-2b pen device and ribavirin treatment for patients with chronic hepatitis C: an evaluation of patient satisfaction.
Aggelopoulou-Tiga P, Dimitroulopoulos D, Kaligeros K, Koutsounas S, Kouroumalis E, Diamanti H, Ionnidou P, Kountouras J, Papaioannou C, Dimopoulou M, Giannoulis G, Ketikoglou I, Protopapas A, Bassaris H, Delis V, Karatapanis S, Manolakopoulos S, Mimidis K, Nikolaou A, Thomopoulos K, Tzelas G, Tsianos E, Kardasi M, Perperas A. Aggelopoulou-Tiga P, et al. Among authors: koutsounas s. Eur J Gastroenterol Hepatol. 2010 Sep;22(9):1058-65. doi: 10.1097/meg.0b013e3283399a1b. Eur J Gastroenterol Hepatol. 2010. PMID: 21061492
Patient's age modifies the impact of the proposed predictors of sustained virological response in chronic hepatitis C patients treated with PEG-interferon plus ribavirin.
Elefsiniotis IS, Pavlidis C, Ketikoglou I, Koutsounas S, Scarmeas N, Pantazis KD, Moulakakis A, Tsianos EV. Elefsiniotis IS, et al. Among authors: koutsounas s. Eur J Intern Med. 2008 Jun;19(4):266-70. doi: 10.1016/j.ejim.2007.06.014. Epub 2008 Jan 15. Eur J Intern Med. 2008. PMID: 18471675
Serum leptin and ghrelin in chronic hepatitis C patients with steatosis.
Pavlidis C, Panoutsopoulos GI, Tiniakos D, Koutsounas S, Vlachogiannakos J, Zouboulis-Vafiadis I. Pavlidis C, et al. Among authors: koutsounas s. World J Gastroenterol. 2011 Dec 14;17(46):5097-104. doi: 10.3748/wjg.v17.i46.5097. World J Gastroenterol. 2011. PMID: 22171144 Free PMC article.
European vs. Egyptian HCV-4 patients with elevated baseline HCV RNA, treated with PEG-IFN-α2a and ribavirin: the role of rapid and early virologic response.
Dimitroulopoulos D, Elefsiniotis I, Pavlidis C, Xinopoulos D, Tsamakidis K, Patsavela S, Kypreos D, Ferderigou A, Korkolis D, Koutsounas S, Saroglou G, Paraskevas E. Dimitroulopoulos D, et al. Among authors: koutsounas s. Hepat Mon. 2010 Summer;10(3):193-8. Epub 2010 Sep 1. Hepat Mon. 2010. PMID: 22308139 Free PMC article.
Common ABCB1 polymorphisms in Greek patients with chronic hepatitis C infection: A comparison with hyperlipidemic patients and the general population.
Gbandi E, Goulas A, Sevastianos V, Hadziyannis S, Panderi A, Koskinas J, Papatheodoridis G, Vasiliadis T, Agapakis D, Protopapas A, Ioannidou P, Zacharakis G, Sinakos E, Koutsounas S, Germanidis G. Gbandi E, et al. Among authors: koutsounas s. Pharmacol Rep. 2016 Apr;68(2):476-82. doi: 10.1016/j.pharep.2015.10.009. Epub 2015 Nov 6. Pharmacol Rep. 2016. PMID: 26922556
16 results